Home' Australian Pharmacist : Australian Pharmacist June 2012 Contents 474 Australian Pharmacist June 2012 I ©Pharmaceutical Society of Australia Ltd.
Continuing Professional Development
The articles in this series are independently researched and compiled by PSA commissioned authors and peer reviewed.
• having knowledge of various
not-for-pro t organisations which
provide helpful resources of information
and fact sheets to assist patients
diagnosed with depression
• providing counselling at the rst time
of dispensing of pharmacotherapy, with
both verbal and written information on
management of depression, treatment
objectives, possible adverse e ects of
therapy and other treatment options
which are available should patients
wish to explore including CBT and
• informing patients about the Better
Access program available under the PBS,
which provides them with subsidised
non-pharmacological treatment options
as adjunctive therapy
• recommending patient information
through various organisations and
websites, including fact sheets and
online modules for CBT and interpersonal
therapy via www.moodgym.anu.edu.au
• providing advice for families and carers
on what information is available to assist
them to cope with family members
su ering from depression
• liaising with GPs regarding
patient concerns, adverse e ects,
and e ectiveness of pharmacotherapy
where relevant, in light of the pharmacist
being the health care professional who
sees the patient on a monthly basis
following initiation of pharmacotherapy.
After talking to Rebecca, you discover
that she does not have a family history of
depression. However she discloses that
occasionally she has felt depressed and
irritated. You advise Rebecca that one in
ve Australians will experience an episode
of depression in their lifetime, and this
may be a short-term situational depression
due to her current life circumstances.
You dispense the script for Rebecca and
provide her with the CMI, advising her
that while somnolence and fatigue are
both common adverse e ects, she may
not experience these symptoms. If she is
concerned, she may commence taking
these tablets on the weekend so as not
to interfere with her work schedule while
she assesses the adverse e ects of therapy
on herself. Advise Rebecca that increased
suicidal thoughts and behaviour can occur
soon after starting antidepressants and she
should consult her GP immediately should
Rebecca is provided with the PSA Self
Care Depression Fact Card and referred
to appropriate organisations for further
assistance and fact sheets about
depression. A referral to a psychologist
for CBT and interpersonal therapy is
suggested to address psychosocial issues
along with pharmacotherapy. You inform
Rebecca of the Better Health Program on
the PBS, which allows her to have access to
psychotherapy as adjunctive treatment, to
help assist handling relationship problems
and di culties at work.
Clinical depression is a debilitating
disease estimated to a ect one in ve
Australians in their lifetime. Depression
is underdiagnosed and undertreated
and it is important for pharmacists to be
aware of the risk factors and symptoms of
depression and know when to refer. Some
research indicates that pharmacists can
have a signi cant positive impact on those
su ering from depression. Pharmacists are
able to provide patients with education
and support, and with diligent counselling
and treatment monitoring can enhance
1. 1. Australian Psychological Society. Understanding and
managing depression [online]. At: www.psychology.org.au/
2. Mental health association service. Depression [online]. At:
3. Depression: introduction [revised Oct 2008]. In: eTG complete
[online]. Melbourne: Therapeutic Guidelines; 2012. At: http://
4. Mayo clinic. Depression (major depression): risk factors [online].
5. MedicineNet. Depression: medicines that cause depression
[online]. At: www.medicinenet.com/script/main/art.
6. European Alliance Against Depression [online]. At: www.eaad.
7. Scheerder G, De Coster I, Van Audenhove C. Pharmacists' role
in depression care: a survey of attitudes, current practices, and
barriers. Psychiatr Serv. 2008; 59(10):1155--60.
8. Crockett J, Taylor S. Consumer perceptions of a project
considering the role of community pharmacists in the
management of depression. Proceedings of the 9th National
Rural Health Conference; 7--10 March 2007; Albury, Australia.
9. Sane Australia [online]. At: www.sane.org.au
10. Beyondblue [online]. At: www.beyondblue.org.au
11. Black Dog Institute [online]. At: www.blackdoginstitute.org.au
12. Moodgym [online]. At: www.moodygym.anu.edu.au
13. Australian Government. Better access to psychiatrists,
psychologist, and general practitioners through the Medical
Benefits Schedule initiative [online]. At: www.health.gov.au/
1. What percentage of Australians are
a ected by depression?
2. Which of the following is NOT a
common risk factor of depression?
a) Hereditary predisposition to
b) Medication use including HRT.
c) Certain personality types.
d) Mild asthma.
3. Which of the following statements is
a) Mood Gym is an online site which
provides free self-help programs
to teach CBT and interpersonal
b) Under the PBS funded Better Access
program, all Australians can have an
initial consultation with a psychologist
subsidised without referral from a GP.
c) Research indicates that pharmacists
have a vital role in the management
of depression, through diagnosis of
depressed patients in the community.
d) All of the above.
4. A study done to assess the role
of community pharmacists in the
management of depression in
rural NSW indicated that patients
who received brochures and
access to videos on depression,
with the initial dispensing of
pharmacotherapy for depression,
had better adherence to their
antidepressants than patients
who received usual care, including
patient counselling and CMI
provision. Is this true or false?
A score of 3 out of 4 attracts 0.75 CPD credits.
Links Archive Australian Pharmacist July 2012 Australian Pharmacist May 2012 Navigation Previous Page Next Page